ABSTRACT: Insulin-like growth factors IIGF) are important mediators of growth, lactation, reproduction, and health. Considerable information on their role in ruminant animals has been learned in the past several years, but the precise mechanisms of their action are not known. The exact biological response of target cells is undoubtedly determined by the developmental state of the cell and synergism with other growth factors. Overall, somatomedins and their binding proteins seem to be major links between cellular developmental processes and nutrient supply. The mechanism by which nutrients control biological actions of somatomedins is not known but clearly involves the synthesis of IGF, as well as their binding proteins and receptors. In ruminants, severe feed restriction decreases circulating concentrations of IGF-I, whereas subtle alterations typical of those that occur in production systems have minimal effect. However, the responses of IGF to somatotropin are affected by modest alterations in nutritional status, including differences in nutritional status that are typically encountered in animal production systems.
Introduction
The somatomedins, or insulin-like growth factors (IGF), have been implicated as being involved in many biological processes. These include preand postnatal growth, lactation, reproduction, and immune function. Therefore, IGF have considerable roles in areas directly applicable to animal production systems, and an increased awareness of the mode of action of IGF as well as the factors that regulate them should enhance our ability to optimize animal production. Current concepts of IGF physiology and the role of IGF in ruminant growth and lactation will be reviewed. The effects of nutrition on IGF and their binding proteins will be emphasized. For more detailed information on IGF physiology, the reader is referred to the proceedings from the 2nd International Conference on IGF (Spencer, 1991) .
Insulin-Like Growth Factors
Both IGF-I and IGF-I1 are found in the bovine. Both peptides have molecular weights of approximately 7,500 Da. The IGF-I molecule contains 70 amino acid residues and IGF-I1 has 67 amino acid residues (Daughaday and Rotwein, 1989) . The amino acid sequence of IGF-I from bovine serum is identical to that isolated from human serum (Honegger and Humbel, 19861, whereas the sequence of IGF-I1 from bovine serum or colostrum differs from that in human serum by three amino acids (Honegger and Humbel, 1986; Francis et al., 1988) . Somatomedins have been detected in all biological fluids examined from numerous species. In the bovine, colostrum and milk have been shown to contain IGF-I and IGF-I1 (Malven et al., 1987; Francis et al., 1988; Campbell and Baumrucker, 19891 . Insulin-like growth factor I has also been detected in bovine follicular fluid (Spicer et al., 1988) and afferent mammary lymph (Lacasse et al., 1991) . Additionally, a truncated form of IGF-I, which lacks the NHrterminal tripeptide (des-IGF-I), has been isolated from colostrum (Francis et al., 19881 . Based on capillary zonal electrophoresis of a n isolated somatomedin fraction, this truncated
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. i, J Figure 1 . Illustration of the possible endocrine, autocrine, and paracrine activities of insulin-like growth factors (IGF) that are regulated by circulating somatotropin.
form is present in only trace quantities, if at all, in milk from midlactation cows (Shimamoto et al., 1992) .
The original somatomedin hypothesis ascribed a n endocrine action to IGF (Figure 1 ). In this scenario, somatotropin (ST) stimulated the liver to produce somatomedins, which in turn entered the circulation and were transported to specific target tissues (Salmon and Daughaday, 1957) . However, subsequent work showed that in addition to liver, many tissues contain the message for IGF-I, although levels were much lower than those found in liver a u n d et Murphy et al., 1987; Han et al., 19881. Therefore, it was postulated that in addition to a n endocrine action, IGF must have the ability to act in an autocrine and(or1 paracrine fashion. Therefore, ST may cause increased IGF synthesis by the liver and may also stimulate the local production of IGF in other tissues. For example, Isaksson et al. (19851 have demonstrated that ST has direct actions on bone, which include a stimulation of local production of IGF (Isgaard et al., 1988; Nilsson et al., 1990) . Thus, the contribution of circulating IGF to bone growth is difficult to separate from the effects of locally produced IGF. For this reason, as well as the presence of circulating binding proteins (see below), it is difficult to determine the physiological relevance of concentrations of IGF in blood or other body fluids. However, circulating concentrations of somatomedins do vary according to physiological state and are responsive to factors such as endocrine and nutritional status. Hodgkinson et al. (1991) used a n antibody that was specific for nmethionyl IGF-I and determined the tissue distribution of n-methionyl IGF-I that was administered intravenously. Their data were indicative of a n endocrine role for IGF-I and demonstrated the extent of target tissues for circulating IGF-I.
As predicted from the somatomedin hypothesis, circulating concentrations of IGF-I increase in cattle given bovine ST (bST) by daily injection (Davis et al., 1987; Breier et al., 1988b; Cohick et al., 1989; ,Elsasser et al., 1989; Prosser et al., 19891 or in prolonged-release formulation (Cisse et al., 199 11. Treatment of lactating cows with bST also is associated with greater IGF-I immunoreactivity in mammary tissue (Glimm et al., 1988) . Administration of bST to lactating cows increases the concentration of IGF-I in milk (Prosser et al., 1989; Schams, 19891 , but the change is minor and concentrations remain within the range of values detected in milk from untreated cows in commercial farm settings . Other factors such as parity, day of lactation, and farm have large influences on IGF-I concentration in milk. The truncated form, des-IGF-I, which is present in colostrum but not in milk, is not induced in milk of midlactation cows treated with bST OShimamoto et al., 1992) .
Unlike those for IGF-I, data for effects of exogenous bST treatment on circulating concentrations of IGF-I1 are equivocal. Some researchers have detected a small increase in IGF-I1 due to bST (Breier et al., 1988b; McGuire et al., 19921, whereas others have failed to detect any significant change (Davis et al., 19871 . When Holstein cows were treated with bST during three periods of the lactation cycle, a n increase in IGF-I1 was only apparent during the dry period but not during early or late lactation (Vicini et al., 1991) . This inconsistency also was observed across studies in rodents and humans, thereby demonstrating that IGF-I1 was minimally ST-dependent (Rechler and Nissley, 19901. 
Insulin-Like Growth Factor

Binding Proteins
In physiological fluids, the majority of somatomedins are bound to soluble, high-affinity binding proteins (IGFBP). Functions of these IGFBP are not understood entirely. The postulated actions of IGFBP vary from circulatory transport vehicles, to retardation of somatomedin degradation, to transvascular IGF movement, to direct modulation of the actions of somatomedins at the target cell either by enhancing or blocking the activity of somatomedins (Baxter, 1988; Clemmons, 1990; Rechler and Nissley, 1990) .
Binding proteins have been examined primarily by two laboratory procedures. Gel filtration of serum after incubation with V25111GF resulted in two major peaks (Elsasser et al., 1988; Hossner et al., 1988 (Rechler and Nissley, 19901 , and the same seems true for bovine serum (Conover, 1990; Cohick et al., 1992) . Some confusion existed in the early literature because of the many names used for similar binding proteins. By agreement of prominent researchers in this field, the most common binding proteins were named IGFBP-1, IGFBP-2, and IGFBP-3 (Ballard et al., 1989) . Their identities were based on amino acid sequences of proteins whose bands were isolated after Western blotting ( Figure 21 .
The majority of circulating IGF is bound to IGFBP represented by bands corresponding to relative molecular masses (M,) of 39,000 and 42,000, which have been shown to be different glycosylation variants of the same gene product (Wood et al., 19881 . The amino acid sequence of this IGFBP was highly homologous to IGFBP-3 purified from human and rat serum [Wood et al., 1988; Shimasaki et al., 1989) and porcine follicular fluid (Shimasaki et al., 19901 . Recently, the gene for bovine IGFBP-3 was cloned (Spratt et al., 19911. The polypeptide consists of 264 amino acids and the sequence is > 80% homologous with IGFBP-3 isolated from humans. Furthermore, Northern analysis of liver IGFBP-? mRNA revealed a single band of 1.65 kb kilobases). This protein is the acid stable subunit of the large molecular weight complex (150 kDa) detected by gel filtration that circulates in blood and binds most of the immunoreactive IGF-I and IGF-I1 that is present (Baxter, 1988; Clemmons, 1990) . The biological effects of purified bovine IGFBP-3 on bovine fibroblasts have been examined in vitro and results demonstrated that, depending on culture conditions, IGFBP-3 could either inhibit or potentiate IGF-I action on aminoisobutyric acid uptake or thymidine incorporation .
Another bovine IGFBP has been purified from bovine kidney (MDBK) cells (Szabo et al., 1988) . The partial amino acid sequence of this peptide is virtually identical to that of the rat IGFBP-2 (Rechler and Nissley, 1990) and recently the gene has been cloned (Bourner et al., 1992) . In vitro, IGFBP-2 inhibits the actions of somatomedins in various cell lines (Rechler and Nissley, 19901 .
The in vivo regulation of at least two IGFBP in bovine serum has been described more fully (Cohick et al., 1992) . As with ST treatment of humans (Clemmons, 19901 , IGFBP-3 was elevated in serum from cows treated with exogenous bST (Vicini et al., 1991; Cohick et al., 1992) . Further, circulating concentrations of IGFBP-2 were decreased in cows treated with bST (McGuire et al., 1991; Vicini et al., 1991; Cohick et al., 1992) . The IGFBP-2 was also present in afferent mammary lymph and levels changed in parallel to changes in concentrations of IGFBP-2 in serum, whereas IGFBP-3 did not (Cohick et al., 19921. Binoux and Hossenlopp (1988) did not detect any 150-kDa IGF-I complex in lymph from humans and suggested that this component cannot cross the capillary barrier. Prosser et al. (1989) demonstrated that IGF-I in milk was associated with binding proteins with molecular weights from 40 to 150 kDa. It seems as though milk is the only fluid, other than serum, to form the entire 150-kDa complex (Rechler and Nissley, 1990) . Using Western analysis, Campbell and Baumrucker (1989) ated with any IGFBP (Campbell and Baumrucker, 1989; Prosser et al., 1989) . The addition of IGF in vitro induced mammary cells to produce their own binding proteins (McGrath et al., 1991) . Vega et al. (1991) demonstrated a decrease in IGFBP activity in mammary secretions before parturition. However, total quantity of IGFBP secreted was greater due to the increase in milk secretion.
Insulin-Like Growth Factor Receptors
Two distinct subtypes of receptors for IGF have been identified (Czech, 1988; Rechler and Nissley, 1986, 19901 . Type I IGF receptor binds IGF-I with equal or greater affinity than IGF-I1 and also binds insulin with very low affinity ( < 2 % of IGF-I). The binding of insulin to the Type I IGF receptor is not surprising because the Type I IGF receptor is similar to IGF-I concentrations in milk (Dehoff et al., 1988; Hadsell et al., 1990) . Type I1 IGF receptors predominate in bovine mammary tissue in both the dry and lactating state, but abundance does not change with the onset of lactation (Dehoff et al., 1988; Hadsell et al., 1990) . Because IGF are not stored in secretory vesicles, but are synthesized and released coordinately, measurement of tissue concentrations of IGF may well represent an indirect measure of the abundance of IGF receptors. By this reasoning, bST treatment of lactating cows may increase the presence of IGF receptors in mammary tissue based on data from Glimm et al. (1988) that demonstrate that immunoreactive IGF-I is increased during bST administration.
Insulin-Like Growth Factors in Growth
and Nutritional Regulation structurally homologous to the insulin receptor.
the peptides and ~-~~b~~~~~ that have intrinsic tyrosine kinase activity. Because of the similarity between Type I IGF receptors and insulin receptors, administration of a pharmacological dose of IGF results in hypoglycemia due to its activity a t the insulin receptor. In vivo, binding to the insulin receptor by endogenous IGF is prevented by the IGFBP. The second type of IGF receptor, Type I1
Both contain disulfide-linked amsubunits that bind The role of IGF in growth is defined more clearly than is its role in lactation. Exogenous IGF-I administration in rats increases weight gain and affects body composition (Skottner et al., 1987) . A growth response was observed in rats after subcutaneous infusion, but not after injection; the difference was attributed to local vs systemic activity (Juskevich and Guyer, 1990) . However, the differential response could also relate to binding protein activity. Thus far, the role of circulating receptor, typically binds IGF-I1 with greater affinity than IGF-I and does not bind This receptor is different from Type I IGF 1GF-I as a mediator of the bST-stimulated growth response is not clearly defined. Pell et al. (1990) reported that 1GF-I concentrations in blood were receptor and receptor' The Type ' I IGF increased severalfold after bST administration to receptor is a sing1e, 250-kDa polypeptide that does not contain and lacks tyrosine kinase lambs and growth rate was increased by 36OlO.
Nutrition clearly affects circulating concentram activity. The extracellular domain represents approximately 93% of the total mass of the receptor and hydrophobic regions* The Type ' I IGF receptor has been found to be the bovine 19881. The mitogenic actions of IGF are mediated through the Type I IGF receptor; however, the Nutritional status also affects circulating confunction of the Type I1 IGF receptor remains to be centrations of IGF-I in ruminants. Circulating determined. Earlier work with the IGF-II/manconcentrations of IGF-I were reduced in growing nose-6-PhosPhate receptor suggested that it may cattle that were severely underfed (Breier et Elsasser et al., 1989; Ronge and Blum, 1989a1 , s~e r a l bovine tissues including mammary gland but differences were not apparent when steers (Dehoff et al., 1988; Collier et al., 1989; were moderately underfed (Breier et al., 1986) . al., 19901, bone (Watanabe et al., 19851, capillaries Administration of somatotropin imposes an addi-(Bar and Boes, 19841, retina (Ocrant et al., 19891 , tional challenge to animals on different dietary and adrenals (Dahmer et al., 1989 Nutritional effects on circulating concentrations of IGF-I1 are not consistent in studies with humans. Reduced circulating concentrations of IGF-I1 were observed in children with kwashiorkor and marasmus, conditions related to protein-energy malnutrition (Soliman et al., 1986) . Merimee et al. (1982) reported decreased serum IGF-I1 in humans fasted for 3 d. However, in other studies, serum concentrations of IGF-I1 in adults were not affected by a 5-d fast or by refeeding diets differing in protein or energy contents (Davenport et al., 1988) . Similarly, in ruminants, feed restriction that reduced weight gain in steers from 1.15 to .23 kg/d did not affect circulating IGF-I1 concentrations in spite of a reduction in IGF-I (Breier et al., 1988b) .
Because circulating concentrations of IGF are dependent on IGFBP, changes in IGF-I during nutrient restriction may reflect changes in IGFBP. No difference was detected in the IGF-I clearance rate, in the half-life of IGF-I, or in the [125111GF-I distribution among the binding protein fractions between fed and starved sheep (Hodgkinson et al., 1987) . However, Elsasser et al. (1988) demonstrated reduced binding of IGF-I in calves due to restriction of intake or parasitism. Thus, nutrition may affect IGFBP in growing ruminants, but this cannot be definitively examined until the IGFBP species have been more rigorously examined.
Insulin-Like Growth Factors in Lactation and Nutritional Regulation
The role of IGF in lactation has been more difficult to ascertain. The increase in circulating concentration of IGF-I after bST administration is suggestive of a role for IGF in the bST-stimulated increase in milk production. The exact mechanism is not known, but the change in the shape of the lactation curve indicates that both increased rates of synthesis and increased mammary cell numbers (greater number of cells or improved maintenance) likely occur (Peel et al., 1981; Bauman et al., 1985) . The low milk levels of plasmin, a serine-protease associated with mammary gland involution, that are maintained during bST treatment (Politis et al., 1990) are consistent with the second suggestion. Whether bST acts directly or indirectly at the mammary gland has not been demonstrated. Low levels of somatotropin receptor mRNA have been detected in mammary cells from heifers (Hauser et al., 1990) and lactating cows (Glimm et al., 19901, but high-affinity receptors have not been detected by more conventional ligand-binding assays (Gertler et al., 1984; Akers, 1985) . Davis et al. (1989) and Prosser et al. (1990) used an intravenous infusion approach to determine whether IGF-I acted directly to stimulate milk synthesis, but results of those studies were inconclusive. Insulinlike growth factors have been shown to stimulate mammary epithelial cell proliferation where activity of des-IGF-I >IGF-I > IGF-I1 (McGrath et al., 1991) . These in vitro studies also demonstrated that IGF stimulate mammary cells to produce IGFBP. Clearly, further work is necessary to determine the role of IGF in lactation.
Low circulating concentrations of IGF-I during early lactation (Figure 3) are associated with low nutrient balances Spicer et al., 1990; Vicini et al., 19911 , which may be considered contradictory to a role for IGF-I in milk production. In the study by cows were fed either an all-forage h a y + silage) diet or the same diet supplemented with concentrates. No significant differences were detected due to diets. When cows were given low-or high-protein diets there was no effect. The IGF-I response to bST treatment was greater during the dry period when cows were in positive nutrient balance than during early lactation (Ronge and Blum, 1989b; Vicini et al., 19911. However, the IGF-I response in late lactation was intermediate and not different from that observed in the dry or early lactation periods (Figure 3 ; Vicini et al., 1991) . These data may indicate that differences in IGF response may not be due entirely to nutrient balance, per se, but may be related to whether the cow is lactating.
The effect of nutritional status was examined more directly by McGuire et al. (1992) in a study 
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using midlactation cows. Diets were in a 2 x 2 factorial arrangement so that intakes were either high or low for NE and CP, the range (80 vs 120% of requirements) being representative for a lactation cycle. Over this range of intakes, there were no differences in circulating concentrations of IGF-I (Figure 41 , although in another study cows fasted for 36 h had decreased blood concentrations of IGF-I (M. A. McGuire and D. E. Bauman, unpublished data) . However, the IGF-I response to bST was diminished by the modest restrictions in NE or CP intake (McGuire et al., 1992;  Figure 41 . Unlike nonruminant animals, it may be more difficult to demonstrate specific effects of protein or energy in ruminants because of the interaction of these nutrients in the rumen. Vicini et al. (1991) and McGuire et al. (1992, Figure 4 ) also measured IGF-I1 concentrations. In these studies, IGF-I1 concentrations were unaffected by either stage of lactation or restriction of CP andtor) NE. Concentrations of IGF-I1 tended to increase most in the study of Vicini et al. (1991) when cows were in positive balance during the dry period, and in the study of McGuire et al. (1992) when cows were fed diets containing an excess of protein and energy during lactation. Concentrations of IGFBF-2 have been measured by RIA, and circulating concentrations were highest in early lactation and significantly lower in the dry period (Vicini et al., 1991) . Concentrations in late lactation were intermediate. In contrast, McGuire et al. (1991) did not detect any differences in circulating concentrations of IGFBP-2 in cows fed diets ranging in CP and(or1 NE content. In both studies, IGFBP-2 was reduced by bST treatment. In the study of McGuire et al. (1991) were lowest when cows were fed the high-NE, high-CP diet (Figure 4) ; this treatment also resulted in the greatest increases in blood IGF-I and daily milk yield.
Because of the negative correlation between energy balance and concentrations of circulating IGF-I in early lactation and the role of IGF-I in steroidogenesis, IGF-I has been implicated as a mediator of effects of energy balance on reproduction. When cattle were fed amounts of DM resulting in BW gain or loss, differences in follicular diameter were obtained but IGF-I concentrations in blood and follicular fluid did not differ, suggesting that IGF-I was not responsible for the observed changes in follicular function (Spicer et al., 1991 (Spicer et al., ). al., 1991 through a postreceptor effect. It should be noted that changes in mRNA with protein restriction have only been reported when the CP percentage of the diet is near maintenance levels (5%1, and, therefore, effects simply could be a consequence of a lack of amino acid availability. This concept is supported in ruminants by the data of Pel1 et al. (19911 in which feed restriction of 16-wk-old lambs reduced concentrations of circulating IGF-I as well as liver mRNA for IGF-I. When lambs were administered bST, feed restriction did not affect IGF-I in the blood or its mRNA in liver.
To date, no studies have been reported on the effects of nutritional status on IGF receptors. Insulin stimulates a rapid increase in IGF-I1 binding in various tissues, which suggests that the Type I1 receptor may be nutritionally regulated (Rechler and Nissley, 1990 ).
Mechanism of Insulin-Like Growth Factor Regulation by Nutrition Implications
The mechanism whereby IGF-I is reduced by fasting may occur a t numerous levels of regulation. Breier et al. (1988a) measured [12511bST binding to liver membranes from steers fed DM a t 1 or 30/0 of BW. Specific binding of bST was higher in steers fed at 3 % of BW and gaining 1.15 kg/d than in those fed at 1% of BW and gaining .23 kg/d. This difference, based on Scatchard analysis, was due to the presence of higher-affinity binding sites (Kd = 11.6 pmol/L) in liver membranes from calves fed at 3% of BW. Similar measurements have not been made from liver taken from dairy cattle or growing animals fed diets with a less severe dietary restriction. Existence of ST receptors with different affinities has not been observed by others for nonruminants, but a change in receptor numbers has been reported (Baxter et al., 1981) . Fasted rats have reduced blood concentrations of IGF-I as well as reduced bST binding to liver membranes. However, when rats were fed diets containing 15 or 5% CP, this restriction reduced circulating IGF-I concentrations but had no effect on somatotropin receptors in liver (Maiter et al., 1988; Thissen et al., 19901 . These data suggest a postreceptor effect in protein-restricted rats. Subsequent data of Thissen et al. (19911 indicate that the reduced IGF-I response may be due to a reduced stability of a 7.5-kb IGF-I mRNA in protein-deficient rats. It has been suggested that energy (glucose or a metabolite) may affect transcription, whereas protein (amino acids) may primarily control translation. Fasting decreases the expression of IGF-I mRNA in many tissues (Rechler and Nissley, 1990; Simmen, 1991) and protein restriction does not diminish the response of IGF-I mRNA to somatotropin. However, circulating concentrations of IGF-I are still reduced during protein restriction (Thissen et Somatomedins seem to be involved in a number of areas applicable to animal production systems. Their physiology is complicated by the presence of specific binding proteins and the potential for local activity. In spite of this insulin-like growth factor I (IGF-I) is reduced during severe feed restriction. Unlike in nonruminant animals, specific effects of energy or protein have not been demonstrated in ruminants, and this may relate to the close interrelationships between protein and energy metabolism that occur in ruminal fermentation. Subtle alterations in nutrition, typical of situations seen in animal production systems, seem to have only minimal effects on circulating IGF. However, substantial differences in IGF-I response to bovine somatotropin administration occur under situations in which basal IGF-I concentrations are unaffected. To date, studies in which nutritional modulation of IGF binding proteins, IGF receptors, and somatotropin receptors were examined are still quite limited. These factors may be important levels of regulation of the somatotropin/IGF axis. 
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